Synapse - Mark Yungjie Jeng

Mark Yungjie Jeng

Groups

Hematology-Oncology Fellows

Research Focus

Graduate Staff; Fellow

Recent additions – View all

Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer
Journal Article

Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
Clinical Cancer Research (2025)

Fulltext@MSK | Save
Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
Journal Article

Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
JCO Precision Oncology (2025)

Fulltext@MSK | Save
Can longitudinal biomarkers guide treatment decisions? Time will tell
Editorial

Jeng, M. Y.; Schoenfeld, A. J.
Clinical Cancer Research (2025)

Fulltext@MSK | Save

Co-authors at MSK

2

Schoenfeld
2

Yu
1

Agrawal
1

Boe
1

Chen
1

Clark
1

Egger
1

Elkrief
1

Gilbert
1

Gomez
1

Hellmann
1

Huang
1

Kris
1

Ma
1

Rizvi
1

Thummal...
1

Veerara...

Types of Work

Publications